Ultragenyx Pharmaceutical Inc.

Q1 2025 13F Holders

Symbol
RARE
CUSIP
90400D108
Type
Equity
Class
COM
Num filers
308
Total reported value, excl. options
$3.25B
Manager Report Date Value ($000) Shares